AbbVie has an exclusive option to globally develop and commercialize AL002. Alector will deliver a data package resulting ...

Over her career, she has held leadership roles in both academic and industry settings where she advanced clinical programs for diseases like AD, frontotemporal dementia (FTD) and PD. Prior to joining ...

Transposon Therapeutics, a biotechnology company developing a platform of novel, orally administered therapies for the treatment of neurodegenerative and aging-related diseases, including Alzheimer's ...

While Emma admitted that she still has "so much to learn about FTD, this community, and how research on the disease is ...

TD Cowen analyst Yaron Werber has maintained their bullish stance on ALEC stock, giving a Buy rating on November 4. Yaron Werber has given his ...

Critical Path Institute today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine Tatton, Ph.D., has been welcomed as the new ...

With its ability to improve neuron health, experimental drug NU-9 has already shown promise in reversing amyotrophic lateral ...

Due to this medical history, Emma said she initially ignored the early warning signs. “As his language started changing, it ...

Researchers at Monash University are conducting clinical trials of a drug that promises to be a game-changer for sufferers of ...

Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a ...

Since 2022, Bruce Willis has been grappling with his health, including an aphasia diagnosis and frontotemporal dementia.

Bruce Willis’s wife Emma Heming has shared new details of the early days of the Die Hard star’s dementia diagnosis Heming ...